As an example, when treated with neutralizing antibodies, mice showed a significant reduction in IL-1β, tumor growth, and neutrophil infiltration.200 Up-to-date research has paid attention to the relationship between the lung microbiome and immune checkpoint inhibitor therapy. This evidence concerns the gene IL1B and neoplasm.